December 12, 2018 10:21 AM EST

Art Krieg moves from CEO post to CSO at Checkmate; Indivior breathes sigh of relief after court ruling

ENDPOINTS

→ Art Krieg is turning in his spot in the CEO’s suite in exchange for the CSO’s job at Checkmate Pharmaceuticals. Barry Labinger, former CEO …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Art Krieg moves from CEO post to CSO at Checkmate; Indivior breathes sigh of relief after court ruling

ENDPOINTS

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Art Krieg moves from CEO post to CSO at Check­mate; In­di­v­ior breathes sigh of re­lief af­ter court rul­ing

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Art Krieg moves from CEO post to CSO at Checkmate; Indivior breathes sigh of relief after court ruling